{"id":"active-reference-comparator","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This entry refers to an 'Active reference comparator' rather than a named drug, indicating it is a control agent used in clinical trials. Without identification of the specific comparator drug, the mechanism cannot be determined.","oneSentence":"Unable to determine specific mechanism without drug identity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:59:12.048Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06878404","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-02-21","conditions":"Arthritis, Psoriatic","enrollment":552},{"nctId":"NCT06641089","phase":"PHASE3","title":"Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response","status":"RECRUITING","sponsor":"MoonLake Immunotherapeutics AG","startDate":"2024-10-15","conditions":"Arthritis, Psoriatic","enrollment":600},{"nctId":"NCT07419672","phase":"NA","title":"Intra Oral Application (IOA) Testing Study of a Stannous Toothpaste","status":"COMPLETED","sponsor":"Church & Dwight Company, Inc.","startDate":"2024-08-12","conditions":"Dental Caries","enrollment":31},{"nctId":"NCT06914102","phase":"","title":"Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2025-01-14","conditions":"Diabetes Mellitus, Type 2, HFpEF - Heart Failure With Preserved Ejection Fraction","enrollment":58387},{"nctId":"NCT06914154","phase":"","title":"Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2025-01-14","conditions":"Diabetes Mellitus, Type 2, Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":11265},{"nctId":"NCT07222696","phase":"NA","title":"Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-01-12","conditions":"Rheumatoid Arthritis (RA","enrollment":250},{"nctId":"NCT03972488","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Advanced Accelerator Applications","startDate":"2020-01-08","conditions":"Gastro-enteropancreatic Neuroendocrine Tumor","enrollment":226},{"nctId":"NCT07315620","phase":"NA","title":"Passive Fit of Implant-Supported Complete-Arch Prostheses Using Digital Workflows","status":"RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2026-01-01","conditions":"Prosthesis and Implant Dentistry","enrollment":30},{"nctId":"NCT07324733","phase":"NA","title":"Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-09-01","conditions":"Primary Sjögren Syndrome, PET","enrollment":60},{"nctId":"NCT07285980","phase":"NA","title":"Comparison of Bier Block and Lidocaine-Propofol Mixture for Prevention of Propofol Injection Pain","status":"COMPLETED","sponsor":"Asma Ladib","startDate":"2025-03-01","conditions":"Propofol Injection Pain","enrollment":180},{"nctId":"NCT07285148","phase":"PHASE1, PHASE2","title":"A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Beijing Pearl Biotechnology Limited Liability Company","startDate":"2026-06","conditions":"Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer","enrollment":253},{"nctId":"NCT06595004","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2024-11-22","conditions":"Chronic Low-back Pain","enrollment":310},{"nctId":"NCT07229430","phase":"NA","title":"Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue","status":"RECRUITING","sponsor":"CLASSYS Inc.","startDate":"2025-10-16","conditions":"Skin Laxity (Submental and Neck), Facial Skin Laxity, Submental Tissue Laxity","enrollment":273},{"nctId":"NCT07037134","phase":"NA","title":"Impact of Auditory Environments on Pain in Fibromyalgia: a 4×4 Crossover Trial","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2025-08-04","conditions":"Fibromyalgia Syndrome","enrollment":88},{"nctId":"NCT07205809","phase":"NA","title":"Comparison of Leakage in Endodontically Treated Teeth Obturated With Different Types of Gutta Percha Coatings and Bioceramic Sealer","status":"NOT_YET_RECRUITING","sponsor":"Pakistan Institute of Medical Sciences","startDate":"2025-11-05","conditions":"Leakage Testing","enrollment":60},{"nctId":"NCT07185074","phase":"PHASE4","title":"Effect of Lidocaine Aerosol Plus Low-dose Cisatracurium vs Conventional-dose Cisatracurium on Intubation Conditions in ERCP - A Randomized Trial","status":"RECRUITING","sponsor":"Jiangang Song","startDate":"2025-01-17","conditions":"Intubation, Intratracheal","enrollment":188},{"nctId":"NCT07071363","phase":"NA","title":"COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS","status":"RECRUITING","sponsor":"Laboratoire Dermatologique ACM","startDate":"2025-06-23","conditions":"Healthy, Melasma (Facial Melasma), Epidermal Melasma","enrollment":40},{"nctId":"NCT07114809","phase":"NA","title":"Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis","status":"RECRUITING","sponsor":"Ospedale Policlinico San Martino","startDate":"2024-09-02","conditions":"Cognitive Impairment, Multiple Sclerosis","enrollment":80},{"nctId":"NCT07029620","phase":"NA","title":"Peripheral Neuropathy Rehabilitation With Stabilometric Platforms (NEUROSTAB)","status":"NOT_YET_RECRUITING","sponsor":"Ospedale Policlinico San Martino","startDate":"2025-06-25","conditions":"Rehabilitation, Balance","enrollment":100},{"nctId":"NCT07017855","phase":"NA","title":"Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-07-01","conditions":"Ventricular Tachycardia, Monomorphic, Ventricular Tachycardia, Sustained, Ventricular Tachycardia (VT)","enrollment":150},{"nctId":"NCT06305416","phase":"PHASE3","title":"A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema","status":"RECRUITING","sponsor":"Incepta Pharmaceuticals Ltd","startDate":"2024-03-30","conditions":"Diabetic Macular Edema, Diabetic Retinopathy, Macular Edema","enrollment":70},{"nctId":"NCT06992310","phase":"NA","title":"Exploration of the Functional Effect of Different Hearing Aid Noise Reduction Algorithms in an Ecologically Valid Conversational Situation","status":"NOT_YET_RECRUITING","sponsor":"Sebastian Griepentrog","startDate":"2025-08","conditions":"Hearing Loss","enrollment":15},{"nctId":"NCT06980194","phase":"NA","title":"A Head-to-Head Comparison of A New Perfusion Tracer, 99mTc-4BOH vs. 13N-NH3 to Evaluate Diagnostic Efficacy of Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-08-01","conditions":"Coronary Artery Disease","enrollment":300},{"nctId":"NCT03428711","phase":"PHASE2","title":"Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis","status":"COMPLETED","sponsor":"Quovadis Associazione","startDate":"2018-03-26","conditions":"Superficial Venous Thrombosis of Leg, Secondary Prevention","enrollment":560},{"nctId":"NCT06935747","phase":"PHASE4","title":"Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)","status":"NOT_YET_RECRUITING","sponsor":"Mario Pérez Sayáns","startDate":"2025-07","conditions":"Bone Loss, Regenerative Inflammation, Third Molars Extraction","enrollment":30},{"nctId":"NCT06771050","phase":"PHASE4","title":"Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Newcastle, Australia","startDate":"2025-03-26","conditions":"Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections","enrollment":2500},{"nctId":"NCT06168539","phase":"NA","title":"Reduction of Microemboli of Air Using a New Developed Air Trap (EmbolessTM) During Haemodialysis","status":"COMPLETED","sponsor":"Umeå University","startDate":"2022-05-11","conditions":"Hemodialysis Complication, Air Embolism, Extracorporeal Circulation; Complications","enrollment":20},{"nctId":"NCT01888445","phase":"PHASE2","title":"A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2013-03-28","conditions":"Renal Anemia Associated With Chronic Renal Failure (CRF)","enrollment":130},{"nctId":"NCT06653907","phase":"PHASE4","title":"Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody","status":"NOT_YET_RECRUITING","sponsor":"Yang ZHANG","startDate":"2024-10-25","conditions":"Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes","enrollment":400},{"nctId":"NCT04877366","phase":"NA","title":"Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2021-07-21","conditions":"Dietary Supplement","enrollment":30},{"nctId":"NCT02920632","phase":"NA","title":"Cognitive Training in Parkinson Study","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2017-09-15","conditions":"Parkinson Disease, Impaired Cognition, Alteration in Cognition","enrollment":167},{"nctId":"NCT04954989","phase":"PHASE1","title":"Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Megalabs","startDate":"2024-10-06","conditions":"Healthy","enrollment":52},{"nctId":"NCT06352138","phase":"PHASE3","title":"Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Megalabs","startDate":"2025-07","conditions":"Anemia of Chronic Kidney Disease","enrollment":280},{"nctId":"NCT02801617","phase":"PHASE3","title":"Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension","status":"TERMINATED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2015-09","conditions":"Primary Open Angle Glaucoma, Ocular Hypertension","enrollment":116},{"nctId":"NCT03332303","phase":"PHASE3","title":"Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy","status":"COMPLETED","sponsor":"Prasco LLC","startDate":"2017-10-26","conditions":"Vulvar and Vaginal Atrophy","enrollment":540},{"nctId":"NCT06311162","phase":"NA","title":"Early Life Intervention in Pediatrics Supported by E-health - SMOKE","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-05-07","conditions":"Smoking Reduction, Asthma in Children, Wheezing","enrollment":160},{"nctId":"NCT06338241","phase":"PHASE4","title":"Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model","status":"RECRUITING","sponsor":"Mario Pérez Sayáns","startDate":"2024-03-02","conditions":"Bone Loss, Regenerative Inflammation","enrollment":30},{"nctId":"NCT06270667","phase":"NA","title":"Effects of Exercise Training in Survivors of Lymphoma","status":"RECRUITING","sponsor":"Norwegian School of Sport Sciences","startDate":"2024-03-20","conditions":"Lymphoma, Physical Exercise, Cardiotoxicity","enrollment":280},{"nctId":"NCT04976088","phase":"PHASE3","title":"Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs","status":"COMPLETED","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2018-05-25","conditions":"Trauma Injury, Inflammation","enrollment":214},{"nctId":"NCT04918667","phase":"PHASE1","title":"Effect of Gamma-cyclodextrin on the Bioavailability of Berberine","status":"NOT_YET_RECRUITING","sponsor":"EuroPharma, Inc.","startDate":"2024-09","conditions":"Drug Absorption","enrollment":16},{"nctId":"NCT05078827","phase":"PHASE3","title":"Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Encube Ethicals Pvt. Ltd.","startDate":"2022-03-01","conditions":"Actinic Keratoses","enrollment":458},{"nctId":"NCT05765409","phase":"NA","title":"Assessment of the Effectiveness of an Integrative Therapy for Cannabis Misuse in Adolescents","status":"UNKNOWN","sponsor":"Centre Hospitalier St Anne","startDate":"2023-02-15","conditions":"Cannabis Use Disorder","enrollment":100},{"nctId":"NCT05223348","phase":"NA","title":"Examining the Role of Perceived Body Boundaries and Spatial Frame of Reference in the Effect of a Mindfulness Meditation in Emotional Eating","status":"COMPLETED","sponsor":"McGill University","startDate":"2021-12-09","conditions":"Eating Behavior","enrollment":81},{"nctId":"NCT03015259","phase":"PHASE3","title":"Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients","status":"COMPLETED","sponsor":"Kindeva Drug Delivery","startDate":"2016-12-29","conditions":"Asthma","enrollment":1762},{"nctId":"NCT04620343","phase":"NA","title":"HelpILO - RCT on EILO Treatment","status":"RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2021-01-01","conditions":"Exercise Induced Laryngeal Obstruction (EILO)","enrollment":350},{"nctId":"NCT03617926","phase":"NA","title":"A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.","status":"COMPLETED","sponsor":"Oystershell NV","startDate":"2018-03-07","conditions":"Head Lice, Pediculosis Capitis","enrollment":70},{"nctId":"NCT03211195","phase":"PHASE1","title":"Sotagliflozin Bioequivalence Study","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-06-29","conditions":"Type 2 Diabetes Mellitus","enrollment":76},{"nctId":"NCT03708263","phase":"NA","title":"Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2020-09-08","conditions":"Erythematotelangiectatic Rosacea","enrollment":1},{"nctId":"NCT01813435","phase":"PHASE3","title":"GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation","status":"COMPLETED","sponsor":"ECRI bv","startDate":"2013-07-01","conditions":"Coronary Artery Disease (CAD)","enrollment":15991},{"nctId":"NCT01138514","phase":"PHASE3","title":"Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":1555},{"nctId":"NCT04691258","phase":"NA","title":"Back Squat Exercise Treatment for Low Back Pain: Clinical Trial","status":"COMPLETED","sponsor":"Universidade Federal de Goias","startDate":"2020-11-30","conditions":"Low Back Pain, Muscle Strength, Visceral Obesity","enrollment":32},{"nctId":"NCT04035161","phase":"","title":"Evaluation of the Antimicrobial Effectiveness of CHG/IPA","status":"COMPLETED","sponsor":"Becton, Dickinson and Company","startDate":"2019-04-17","conditions":"Microbial Colonization","enrollment":1935},{"nctId":"NCT01244490","phase":"PHASE3","title":"Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Shire","startDate":"2011-01-17","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":338},{"nctId":"NCT04402762","phase":"PHASE1, PHASE2","title":"Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-12-20","conditions":"Enoxaparin","enrollment":20},{"nctId":"NCT02654769","phase":"PHASE3","title":"A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-02","conditions":"Actinic Keratosis","enrollment":441},{"nctId":"NCT04224350","phase":"PHASE4","title":"Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2018-12-17","conditions":"Kidney Transplant","enrollment":184},{"nctId":"NCT04018911","phase":"NA","title":"Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2019_20","status":"COMPLETED","sponsor":"Sonova AG","startDate":"2019-06-03","conditions":"Hearing Loss","enrollment":22},{"nctId":"NCT03729284","phase":"PHASE4","title":"A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2020-03-30","conditions":"Healthy","enrollment":""},{"nctId":"NCT03794154","phase":"PHASE4","title":"A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2020-03-30","conditions":"Healthy","enrollment":""},{"nctId":"NCT02037165","phase":"PHASE1","title":"Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-01-21","conditions":"Healthy","enrollment":25},{"nctId":"NCT04008732","phase":"PHASE1","title":"Evaluating MED2005 & Nitrostat Bioavailability","status":"COMPLETED","sponsor":"Futura Medical Developments Ltd.","startDate":"2017-11-15","conditions":"Erectile Dysfunction","enrollment":40},{"nctId":"NCT03991637","phase":"NA","title":"Non-Invasive Blood Test Cross-Validation Study","status":"COMPLETED","sponsor":"Joseph Allen Jr.","startDate":"2018-07-18","conditions":"Reproducibility of Results, Safety Issues","enrollment":90},{"nctId":"NCT02084511","phase":"PHASE1","title":"Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-03","conditions":"Pain, Postoperative","enrollment":80},{"nctId":"NCT01848353","phase":"NA","title":"Financial Incentives to Exercise for Adolescents","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2013-05","conditions":"Insulin Resistance, Obesity, Sedentary Lifestyle","enrollment":142},{"nctId":"NCT03257189","phase":"NA","title":"Evaluation of Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data","status":"COMPLETED","sponsor":"MC10 Inc.","startDate":"2017-07-31","conditions":"Healthy Normals","enrollment":30},{"nctId":"NCT02989909","phase":"NA","title":"Clinical Evaluation of CATS Tonometer Prism","status":"COMPLETED","sponsor":"Intuor Technologies, Inc.","startDate":"2017-01","conditions":"Ocular Hypertension","enrollment":86},{"nctId":"NCT02533505","phase":"PHASE4","title":"Phase IV O2 Consumption Study in COPD Patients.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-08-25","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":51},{"nctId":"NCT02628730","phase":"NA","title":"Pulmonary Vein Reconnection Following Ablation Index-guided Ablation: a Success Evaluation","status":"UNKNOWN","sponsor":"Liverpool Heart and Chest Hospital NHS Foundation Trust","startDate":"2016-02","conditions":"Atrial Fibrillation","enrollment":40},{"nctId":"NCT02916251","phase":"PHASE2","title":"ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon","status":"COMPLETED","sponsor":"Zealand Pharma","startDate":"2016-12-01","conditions":"Diabetes Mellitus Type 1","enrollment":38},{"nctId":"NCT01425814","phase":"PHASE2","title":"Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2011-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":87},{"nctId":"NCT02902666","phase":"PHASE1","title":"Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2016-04","conditions":"Healthy","enrollment":46},{"nctId":"NCT02398812","phase":"NA","title":"The Interprofessional Medication Assessment for Older Patients","status":"UNKNOWN","sponsor":"East Savo Hospital District","startDate":"2015-02","conditions":"Multimorbidity, Polypharmacy","enrollment":514},{"nctId":"NCT01766024","phase":"PHASE1","title":"Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers","status":"COMPLETED","sponsor":"Biocad","startDate":"2013-02","conditions":"Healthy","enrollment":32},{"nctId":"NCT02089581","phase":"PHASE1","title":"A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication","status":"COMPLETED","sponsor":"Mundipharma Research Limited","startDate":"2014-04","conditions":"Pain","enrollment":32},{"nctId":"NCT02180464","phase":"PHASE2","title":"A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis","status":"COMPLETED","sponsor":"Almirall, S.A.","startDate":"2014-06","conditions":"Psoriasis","enrollment":40},{"nctId":"NCT01283698","phase":"PHASE2","title":"Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis","status":"COMPLETED","sponsor":"Almirall, S.A.","startDate":"2011-01","conditions":"Psoriasis","enrollment":20},{"nctId":"NCT01877681","phase":"PHASE2","title":"Reference Nurse Program for Pressure Ulcers in Primary Care","status":"COMPLETED","sponsor":"Basque Health Service","startDate":"2012-10","conditions":"Pressure Ulcers","enrollment":58},{"nctId":"NCT02279563","phase":"PHASE2","title":"A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Apotex Inc.","startDate":"2013-12","conditions":"Seasonal Allergic Rhinitis","enrollment":595},{"nctId":"NCT01365598","phase":"PHASE3","title":"Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2011-12","conditions":"Falciparum Malaria","enrollment":468},{"nctId":"NCT01327261","phase":"PHASE4","title":"Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Buenos Aires","startDate":"2009-08","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT01086488","phase":"PHASE2","title":"Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma","status":"UNKNOWN","sponsor":"Ministry of Health, Malaysia","startDate":"2009-01","conditions":"Nasopharyngeal Carcinoma","enrollment":66}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Active reference comparator","genericName":"Active reference comparator","companyName":"Janssen Research & Development, LLC","companyId":"janssen-research-development-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}